New QIAseq® Multimodal Panels

New QIAseq® Multimodal Panels

Molecular Biology

July 02, 2020

High-throughput next-generation sequencing (NGS) technologies continue to provide a wealth of sequence information, resulting in significant advances and new discoveries in a wide range of research areas.
To enhance your specific NGS-based research and help you achieve your goals, QIAGEN has developed the broadest portfolio of dedicated NGS target enrichment, library preparation and single cell solutions: the QIAseq product family, including the QIAseq Targeted DNA Panels, QIAseq Targeted RNA Panels and now the newly released QIAseq® Multimodal Panels
The New QIAseq® Multimodal Panels-Multiple insights from a single extraction

  • The ONLY single consolidated workflow for DNA + RNA library prep using Total Nucleic Acids as input
  • Operational efficiency driven by a streamlined workflow for the analysis of DNA + RNA
  • Detect low-frequency variants confidently by incorporating Unique Molecular Indices (UMIs)
  • Reduce index hopping and read mis-assignment with Unique Dual Indices (UDIs)
  • Pre-built NGS data analysis workflows for multi-variant detection
  • Detect both known and novel fusions
  • Cover GC-rich regions such as CEBPA very efficiently
New hope for the development of Alzheimer

New hope for the development of Alzheimer's disease therapeutics from Qiagen!

Molecular Biology

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by two types of lesions in the brain: extracellular senile plaques consisting of APP-derived amyloid ß (Aß) peptide and intracellular neurofibrillary tangles build out of hyperphosphorylated microtubule-associated tau protein.

August 30, 2018 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us